Researchers at Massachusetts Institute of Technology used artificial-intelligence tools to design new antibiotic compounds that successfully cleared MRSA infections in animal models. The drugs were created by screening dozens of chemical candidates via AI and then testing them on mice infected with MRSA. MRSA infections are increasingly resistant to standard antibiotics, so new treatment options could make a big difference.
